Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato2018
StatusUdgivet - 2018
BegivenhedISOQOL 25th Annual Conference - Dublin, Irland
Varighed: 25. okt. 201827. okt. 2018

Konference

KonferenceISOQOL 25th Annual Conference
LandIrland
ByDublin
Periode25/10/201827/10/2018

Citer dette

@conference{40417bbee84144ab8039bae850c4c167,
title = "Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial",
author = "Henrik Eshoj and {Kongsgaard Nielsen}, Lene and Niels Abildgaard and Henrik Gregersen",
year = "2018",
language = "English",
note = "ISOQOL 25th Annual Conference ; Conference date: 25-10-2018 Through 27-10-2018",

}

Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial. / Eshoj, Henrik; Kongsgaard Nielsen, Lene; Abildgaard , Niels; Gregersen, Henrik.

2018. Abstract fra ISOQOL 25th Annual Conference, Dublin, Irland.

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

TY - ABST

T1 - Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial

AU - Eshoj, Henrik

AU - Kongsgaard Nielsen, Lene

AU - Abildgaard , Niels

AU - Gregersen, Henrik

PY - 2018

Y1 - 2018

M3 - Conference abstract for conference

ER -